Ibuprofen Treatment for Closure of Patent Ductus Arteriosus is Not Associated with Increased Risk of Neuropathology

Overview

Journal Pediatr Res

Specialties Biology
Pediatrics

Date 2010 Jun 29

PMID 20581742

Citations 4

Authors

Michelle Loeliger

Amy Shields

Donald McCurnin

Ronald I Clyman

Bradley Yoder

Terrie E Inder

Sandra M Rees

Affiliations

Soon will be listed here.

Abstract

Ibuprofen is an effective pharmacological intervention for closure of a patent ductus arteriosus (PDA) in preterm infants and is an alternative to surgical ligation; however, it is not certain whether ibuprofen treatment is associated with adverse effects on the brain. Therefore, this study examined neuropathological outcomes of ibuprofen therapy for a PDA. Fetal baboons were delivered at 125 d of gestation (dg; term ∼185 dg) by caesarean section, given surfactant, and ventilated for 14 d with positive pressure ventilation (PPV). Baboons were randomly allocated to receive either ibuprofen (PPV+ ibuprofen, n = 8) or no therapy (PPV, n = 5). Animals were killed on day 14 and brains assessed for cerebral growth, development, and neuropathology. Body and brain weights, the total volume of the brain, and the surface folding index (measure of brain growth) were not different (p > 0.05) between PPV+ ibuprofen-treated and PPV animals. There was no difference (p > 0.05) in the number of myelin basic protein-immunoreactive (IR) oligodendrocytes, glial fibrillary acid protein-IR astrocytes, or Iba1-IR macrophages/microglia in the forebrain. No overt cerebellar alterations were observed in either group. Ibuprofen treatment for PDA closure in the preterm baboon neonate is not associated with any increased risk of neuropathology or alterations to brain growth and development.

Citing Articles

Determinants of Indices of Cerebral Volume in Former Very Premature Infants at Term Equivalent Age.

Naud A, Schmitt E, Wirth M, Hascoet J PLoS One. 2017; 12(1):e0170797.

PMID: 28125676 PMC: 5268368. DOI: 10.1371/journal.pone.0170797.

Animal models of bronchopulmonary dysplasia. The preterm baboon models.

Yoder B, Coalson J Am J Physiol Lung Cell Mol Physiol. 2014; 307(12):L970-7.

PMID: 25281639 PMC: 4269686. DOI: 10.1152/ajplung.00171.2014.

MR imaging correlates of white-matter pathology in a preterm baboon model.

Griffith J, Shimony J, Cousins S, Rees S, McCurnin D, Inder T Pediatr Res. 2012; 71(2):185-91.

PMID: 22258130 PMC: 3590025. DOI: 10.1038/pr.2011.33.

Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?.

Fanos V, Pusceddu M, Dessi A, Marcialis M Clinics (Sao Paulo). 2011; 66(12):2141-9.

PMID: 22189742 PMC: 3226612. DOI: 10.1590/s1807-59322011001200022.

References

Aranda J, Clyman R, Cox B, van Overmeire B, Wozniak P, Sosenko I . A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol. 2008; 26(3):235-45. DOI: 10.1055/s-0028-1103515. View

Rees S, Camm E, Loeliger M, Cain S, Dieni S, McCurnin D . Inhaled nitric oxide: effects on cerebral growth and injury in a baboon model of premature delivery. Pediatr Res. 2007; 61(5 Pt 1):552-8. DOI: 10.1203/pdr.0b013e318045be20. View

Loeliger M, Inder T, Cain S, Ramesh R, Camm E, Thomson M . Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics. 2006; 118(4):1640-53. DOI: 10.1542/peds.2006-0653. View

Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L . Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg. 2005; 81(1):231-4. DOI: 10.1016/j.athoracsur.2005.03.141. View

McCurnin D, Seidner S, Chang L, Waleh N, Ikegami M, Petershack J . Ibuprofen-induced patent ductus arteriosus closure: physiologic, histologic, and biochemical effects on the premature lung. Pediatrics. 2008; 121(5):945-56. PMC: 11790498. DOI: 10.1542/peds.2007-2051. View

Coalson J, Winter V, Siler-Khodr T, Yoder B . Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med. 1999; 160(4):1333-46. DOI: 10.1164/ajrccm.160.4.9810071. View

Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts R, Saigal S . Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001; 344(26):1966-72. DOI: 10.1056/NEJM200106283442602. View

Kabra N, Schmidt B, Roberts R, Doyle L, Papile L, Fanaroff A . Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007; 150(3):229-34, 234.e1. DOI: 10.1016/j.jpeds.2006.11.039. View

Marlow N, Wolke D, Bracewell M, Samara M . Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005; 352(1):9-19. DOI: 10.1056/NEJMoa041367. View

10.

Bodeau-Livinec F, Marlow N, Ancel P, Kurinczuk J, Costeloe K, Kaminski M . Impact of intensive care practices on short-term and long-term outcomes for extremely preterm infants: comparison between the British Isles and France. Pediatrics. 2008; 122(5):e1014-21. DOI: 10.1542/peds.2007-2976. View

11.

Couser R, Hoekstra R, Ferrara T, Wright G, Cabalka A, Connett J . Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. Arch Pediatr Adolesc Med. 2000; 154(6):598-602. DOI: 10.1001/archpedi.154.6.598. View

12.

Rees S, Loeliger M, Munro K, Shields A, Dalitz P, Dieni S . Cerebellar development in a baboon model of preterm delivery: impact of specific ventilatory regimes. J Neuropathol Exp Neurol. 2009; 68(6):605-15. PMC: 2766603. DOI: 10.1097/NEN.0b013e3181a39b3f. View

13.

Fowlie P, Davis P . Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003; 88(6):F464-6. PMC: 1763231. DOI: 10.1136/fn.88.6.f464. View

14.

Creeley C, Olney J . The young: neuroapoptosis induced by anesthetics and what to do about it. Anesth Analg. 2009; 110(2):442-8. DOI: 10.1213/ANE.0b013e3181c6b9ca. View

15.

Loeliger M, Inder T, Dalitz P, Cain S, Camm E, Yoder B . Developmental and neuropathological consequences of ductal ligation in the preterm baboon. Pediatr Res. 2008; 65(2):209-14. PMC: 2686107. DOI: 10.1203/PDR.0b013e31818d6d0b. View

16.

Marlow N, Hennessy E, Bracewell M, Wolke D . Motor and executive function at 6 years of age after extremely preterm birth. Pediatrics. 2007; 120(4):793-804. DOI: 10.1542/peds.2007-0440. View

17.

Clyman R . Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006; 89(4):330-5. DOI: 10.1159/000092870. View

18.

Clyman R, Chorne N . Patent ductus arteriosus: evidence for and against treatment. J Pediatr. 2007; 150(3):216-9. PMC: 2723062. DOI: 10.1016/j.jpeds.2006.12.048. View

19.

Yoder B, Siler-Khodr T, Winter V, Coalson J . High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med. 2000; 162(5):1867-76. DOI: 10.1164/ajrccm.162.5.9912145. View

20.

Chorne N, Leonard C, Piecuch R, Clyman R . Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007; 119(6):1165-74. DOI: 10.1542/peds.2006-3124. View